The 6 Minute Walk Test as a predictor of mortality in idiopathic pulmonary fibrosis: A systematic review
Respiratory Investigation · 2025
DOI: 10.1016/j.resinv.2025.03.005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Respiratory Investigation, 2025. Verfasst von Eugenio Vecchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: St Catherine's College, University of Oxford, OX1 3UJ, Oxford, United Kingdom. Electronic address: eugenio.vecchi@stcatz.ox.ac.uk. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Walk Test. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The 6-min walk test (6MWT) is frequently used in pulmonary fibrosis (PF) research. It evaluates an individual's sub-maximal exercise performance by measuring the distance they walk and their vital signs across 6 min. In research studies, the 6-min walk distance (6MWD) is often used as a surrogate marker for disease progression. The aim of this study was to systematically assess the association between 6MWT parameters and mortality in PF. METHODS: MEDLINE, EMBASE, CINAHL, and CENTRAL databases were searched for studies reporting mortality and 6MWD in patients with PF. Study quality was assessed using a modified Newcastle-Ottawa Scale. Studies were included if they reported associations between the 6MWT in pulmonary fibrosis and mortality. Results were presented as a narrative synthesis. RESULTS: 2312 studies were identified, 22 studies met the pre-defined inclusion criteria, comprising 5940 Idiopathic PF patients. Baseline 6MWD was found to be loosely associated with mortality (Ranges: univariate HR 0.89-4.72, multivariate HR 0.96-2.65), while a decrease in 6MWD across 24-weeks was correlated with a higher risk of mortality (Ranges: univariate HR 2.25-4.81, multivariate HR 1.72-4.3). DISCUSSION: This review found that a low baseline 6MWD, and a 6-month decrease in 6MWD were strongly correlated with increased mortality in Idiopathic PF patients. As the 6MWT is a safe, easy-to-conduct test, it is appropriate for use as a marker of patient prognosis, in both clinical and research settings. OPEN SCIENCE FRAMEWORK PROTOCOL REGISTRATION: DOI 10.17605/OSF.IO/3D7BV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St Catherine's College, University of Oxford, OX1 3UJ, Oxford, United Kingdom. Electronic address: eugenio.vecchi@stcatz.ox.ac.uk.
- St Catherine's College, University of Oxford, OX1 3UJ, Oxford, United Kingdom.
- Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, OX3 7DQ, Oxford, United Kingdom.
- Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital Level 6, OX3 9DU Oxford, United Kingdom. Electronic address: ashok.handa@nds.ox.ac.uk.
Zitieren
APA
Vecchi, E., Kilbey, T., Sheth, M., Eleanor Stride, & Ashok Handa (2025). The 6 Minute Walk Test as a predictor of mortality in idiopathic pulmonary fibrosis: A systematic review. Respiratory Investigation. https://doi.org/10.1016/j.resinv.2025.03.005
Vancouver
Vecchi E, Kilbey T, Sheth M, Eleanor Stride, Ashok Handa. The 6 Minute Walk Test as a predictor of mortality in idiopathic pulmonary fibrosis: A systematic review. Respiratory Investigation. 2025. doi:10.1016/j.resinv.2025.03.005
BibTeX
@article{Vecchi2025,
author = {Vecchi, Eugenio and Kilbey, Timothy and Sheth, Mihir and Eleanor Stride and Ashok Handa},
title = {The 6 Minute Walk Test as a predictor of mortality in idiopathic pulmonary fibrosis: A systematic review},
journal = {Respiratory Investigation},
year = {2025},
doi = {10.1016/j.resinv.2025.03.005}
}
EUVIMED